Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis”

18 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 18 results

Testing effectiveness (Phase 2)Study completedNCT03274375
What this trial is testing

Immunoadsorption Therapy in Managing NMDAR Antibodies Encephalitis

Who this might be right for
Anti-NMDAR Encephalitis
Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Looking for participantsNCT06867991
What this trial is testing

Safety and Efficacy of Combined B Cell Depleting theRapy And Daratumumab In Autoimmune Encephalitis

Who this might be right for
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
The First People's Hospital of Changzhou 200
Not applicableUnknownNCT04339127
What this trial is testing

Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis

Who this might be right for
Autoimmune EncephalitisAnti NMDA Receptor EncephalitisHerpetic Encephalitis
Hospices Civils de Lyon 12
Not applicableLooking for participantsNCT05017142
What this trial is testing

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Who this might be right for
Optic NeuritisTransverse MyelitisAcute Disseminated Encephalomyelitis+15 more
University of Bern 500
Not applicableUnknownNCT02559089
What this trial is testing

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Who this might be right for
Anti-NMDA Receptor Enphalitis
Beijing Tongren Hospital 400
Not applicableUnknownNCT05738668
What this trial is testing

Clinical-immunological Features of Anti-NMDAR Encephalitis

Who this might be right for
Anti NMDA Receptor Encephalitis
Hospices Civils de Lyon 400
Not applicableStudy completedNCT01865578
What this trial is testing

Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis

Who this might be right for
Anti-NMDA Receptor Encephalitis
Charite University, Berlin, Germany 40
Testing effectiveness (Phase 2)Looking for participantsNCT07093333
What this trial is testing

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Who this might be right for
Anti-N-methyl-D-aspartate Receptor (NMDAR) Encephalitis (ANRE)Anti-N-methyl-D-aspartate Receptor (NMDAR) Antibody-associated Psychiatric DiseaseAutoimmune Encephalitis
Arialys Australia Pty Ltd 30
Not applicableUnknownNCT02443350
What this trial is testing

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area

Who this might be right for
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Jia Wei Wang,MD 400
Large-scale testing (Phase 3)Active Not RecruitingNCT05503264
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis

Who this might be right for
NMDAR Autoimmune EncephalitisLGI1 Autoimmune Encephalitis
Hoffmann-La Roche 122
Not applicableStudy completedNCT06915103
What this trial is testing

A Case Report of NMDAR Encephalopathy

Who this might be right for
Anti-NMDA Receptor EncephalitisMature TeratomaParaneoplastic Syndromes
Mayo Clinic 1
Not applicableUnknownNCT06183788
What this trial is testing

Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage

Who this might be right for
Anti-NMDA Receptor Encephalitis
Fundacion Clinic per a la Recerca Biomédica 20
Early research (Phase 1)Study completedNCT06575153
What this trial is testing

Phase 1 Study of ART5803 in Healthy Participants

Who this might be right for
Autoimmune Encephalitis
Arialys Therapeutics 64
Testing effectiveness (Phase 2)Looking for participantsNCT06510283
What this trial is testing

Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis

Who this might be right for
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
Beijing Tongren Hospital 10
Not applicableUnknownNCT05280600
What this trial is testing

Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis

Who this might be right for
Anti-N-Methyl-D-Aspartate Receptor EncephalitisAutoimmune Encephalitis
King's College London 75
Testing effectiveness (Phase 2)Looking for participantsNCT07822776
What this trial is testing

Efgartigimod in Anti-NMDA Receptor Encephalitis.

Who this might be right for
Encephalitis Autoimmune
Beijing Tongren Hospital 20
Early research (Phase 1)Study completedNCT06753955
What this trial is testing

Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants

Who this might be right for
Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor AntibodyAutoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)Autoimmune Encephalitis
Arialys Therapeutics 7
Not applicableStudy completedNCT06023160
What this trial is testing

Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis

Who this might be right for
Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
Erasmus Medical Center 714